Application 216187
- Type
- ANDA
- Sponsor
- CHANGZHOU PHARM
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TICAGRELOR | TICAGRELOR | TABLET;ORAL | 60MG | No | No |
| 002 | TICAGRELOR | TICAGRELOR | TABLET;ORAL | 90MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A216187-001 | TICAGRELOR | TICAGRELOR | 60MG | TABLET / ORAL | AB | 2025-10-28 | |
| A216187-002 | TICAGRELOR | TICAGRELOR | 90MG | TABLET / ORAL | AB | 2025-10-28 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A216187-001 | AB |
| A216187-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A216187-001 | TICAGRELOR | 60MG | TABLET / ORAL | AB | 2025-10-28 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A216187-002 | TICAGRELOR | 90MG | TABLET / ORAL | AB | 2025-10-28 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A216187-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A216187-002 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ticagrelor | TICAGRELOR | Changzhou Pharmaceutical Factory | 751410c1-452b-400b-a640-d31623a6fda3 | 2025-10-29 | Boxed warning, Warnings, Adverse reactions | 216187 ANDA216187 |
| Ticagrelor | TICAGRELOR | BIONPHARMA INC. | 4239fc4c-dae6-eb51-e063-6394a90a00d5 | 2025-10-28 | Boxed warning, Warnings, Adverse reactions | 216187 ANDA216187 |